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Engineered Extracellular Vesicles
Loaded With miR-124 Attenuate
Cocaine-Mediated Activation of
Microglia
Ernest T. Chivero, Ke Liao, Fang Niu, Ashutosh Tripathi, Changhai Tian, Shilpa Buch*
and Guoku Hu*
Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE,
United States
MicroRNA-124 (miR-124), a brain-enriched microRNA, is known to regulate microglial
quiescence. Psychostimulants such as cocaine have been shown to activate microglia
by downregulating miR-124, leading, in turn, to neuroinflammation. We thus rationalized
that restoring the levels of miR-124 could function as a potential therapeutic approach
for cocaine-mediated neuroinflammation. Delivering miRNA based drugs in the brain
that are effective and less invasive, however, remains a major challenge in the field.
Herein we engineered extracellular vesicles (EVs) and loaded them with miR-124
for delivery in the brain. Approach involved co-transfection of mouse dendritic cells
with Dicer siRNA and RVG-Lamp2b plasmid to deplete endogenous miRNAs and
for targeting the CNS, respectively. Mouse primary microglia (mPm) were treated
with purified engineered EVs loaded with either Cy5-miR-124 or Cy5-scrambled
miRNA oligos in the presence or absence of cocaine followed by assessing EV
uptake and microglial activation. In vivo studies involved pretreating mice intranasally
with engineered EVs followed by cocaine injection (20 mg/kg, i.p.). mPm exposed
to EV-miR-124 exhibited reduced expression of miR-124 targets – TLR4 and
STAT3 as well as ERK-1/2 and Iba1. In cocaine administered mice, EV-Cy5-miR-
124 delivered intranasally were detected in the CNS and significantly reduced the
expression of inflammatory markers TLR4, MYD88, STAT3 and NF-kB p65 while
also downregulating the microglial activation marker, Iba1. Collectively, these findings
suggest that engineered EVs can deliver miR-124 into the CNS, thereby alleviating
cocaine-mediated microglial activation. Manipulating EV miRNAs can thus be envisioned
as an efficient means for delivery of RNA-based therapeutics to target organs.
Keywords: extracellular vesicles, miR-124, cocaine, microglia, neuroinflammation
INTRODUCTION
Cocaine is a highly potent and addictive brain stimulant that is associated with increased immune
reactivity and inflammation in humans (Fox et al., 2012; Ersche et al., 2014; Levandowski et al.,
2016; Moreira et al., 2016; Pianca et al., 2017) and neuroinflammation in animal models (Guo
et al., 2015; Periyasamy et al., 2017). Worldwide, nearly 22.5 million people are affected by cocaine
use disorder (CUD), contributing to increased global health care costs and associated social and
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economic impact (Pomara et al., 2012). Accumulating evidence
suggests a close link between drug abuse and neuroinflammation
(Crews et al., 2011; Clark et al., 2013). In particular, cocaine
has been shown to activate microglia both in in vitro and
in vivomodel systems by mechanisms involving dysregulation of
microRNAs (miRNAs) and their target genes (Guo et al., 2016;
Periyasamy et al., 2017). A recent study has shown that exposure
of microglia to cocaine downregulated the expression of miR-
124 with concomitant upregulation of its targets such as TLR4,
MYD88 and STAT3 (Periyasamy et al., 2017).
MiR-124 is a brain-enriched miRNA that plays key roles
in neurogenesis, synaptic strength and transmission, and glia-
neuronal interactions essential for the maintenance of brain
homeostasis (Sun et al., 2015; Han et al., 2019). Additionally,
miR-124 is highly expressed in microglia and is critical for
maintaining microglia in a quiescent state (Ponomarev et al.,
2011; Veremeyko et al., 2013; Svahn et al., 2016). Notably,
altered expression of miR-124 has been associated with multiple
neuroinflammatory disorders such as Parkinson’s (Kanagaraj
et al., 2014; Wang et al., 2016; Dong et al., 2018; Yao et al., 2018,
2019), Alzheimer’s Diseases (Lukiw, 2007; Smith et al., 2011; Fang
et al., 2012; Zhou et al., 2018), and Huntington’s disease (Johnson
and Buckley, 2009). Here we sought to investigate whether
restoration of miR-124 in the CNS via intranasal administration
of miR-124-enriched EVs could attenuate cocaine-induced
neuroinflammation in mice.
Gene therapy is becoming a promising tool for the treatment
of human diseases that cannot be cured by conventional
therapies. RNA-based approaches such as miRNAs, siRNA, and
antisense RNA that are potent sequence-selective inhibitors
or activators of transcription are rapidly being developed as
therapeutics. EVs that can efficiently shuttle or deliver small
molecules between cells have been considered as promising
therapeutic delivery conduits for treatment of various diseases,
including neurological disorders. Several studies have reported
and reviewed the potential of EVs in the delivery of miRNAs
for the treatment of various diseases (Zhuang et al., 2011; Vader
et al., 2016; Rufino-Ramos et al., 2017; Osorio-Querejeta et al.,
2018, 2020; Long et al., 2020). EVs have also been successfully
utilized for in vivo delivery of siRNAs to specific cell types and
tissues in mice (Van Den Boorn et al., 2011; Hu et al., 2018;
Liao et al., 2019; Zhao et al., 2020). In the current study, we
attempted to deliver exogenousmiR-124 to in vitromicroglia, and
to in vivo brain in mice, respectively, via engenered EVs released
by donor cells depleted of endogenous miRNAs by knockdown
of dicer. Intranasal administration of EVs is a potential non-
invasive method for rapid delivery of EV-encapsulated drug(s)
into the brain via cell uptakes including microglia and other
resident CNS immune cells (Visweswaraiah et al., 2002; Lakhal
andWood, 2011; Zhuang et al., 2011; Grassin-Delyle et al., 2012).
We envisage that manipulating EVs can be utilized as an efficient,
non-invasive means to deliver miRNAs to target organs.
The current study was aimed at testing the hypothesis
that intranasal administration of engineered EV-miR-124
could efficiently deliver miR-124 to the CNS microglial
cells and thus dampen cocaine-mediated activation and
ensuing neuroinflammation. Our findings demonstrated that
EV-Cy5-miR-124 was taken up by the microglia in vitro,
resulting in downregulation of the miR-124 targets – TLR4 and
STAT3, and also amelioration of cocaine-mediated microglial
activation, as evidenced by downregulation of Iba1 and ERK1/2.
Consistently, intranasal delivery of Cy5-miR-124 loaded EVs
in cocaine-administered mice not only resulted in attenuation
of cocaine-mediated upregulation of TLR4, STAT3, NF-kB p65
and MYD88, but also abrogated cocaine-mediated activation
of microglia (Iba1) in the brain. Taken together, our findings
suggest that intranasal delivery of engineered EV-miR-124 to
the CNS could alleviate cocaine-mediated microglial activation.
Manipulating the EV cargo with RNA based therapeutics can
thus be envisioned as an efficient, non-invasive means for specific
delivery of miRNAs to target organs such as the brain.
MATERIALS AND METHODS
Reagents
Antibodies and reagents used in this work were purchased from
the indicated sources: Lamp2 (NB300-591; Novus, Centennial,
CO, United States); CD63 (ab216130; Abcam, Cambridge, MA,
United States), TLR4 (NB100-56566 Novus, Centennial, CO,
United States), Iba1 (Novus NB1001028 or Wako; 19-19741),
STAT3 (4904S, Cell Signaling, MA, United States), ERK1 /2
(9107S; Cell Signaling, MA, United States), goat anti-mouse-
HRP (Santa Cruz Biotechnology; sc-2005), and goat anti-rabbit-
HRP (Santa Cruz Biotechnology; sc-2004); NFkB p65 (16502,
Abcam, Cambridge, MA, United States); MYD88 (ab2064;
Abcam, Cambridge, MA, United States); β-Actin (A1978; Sigma-
Aldrich, St. Louis, MO, United States). Cocaine hydrochloride
(C5776) was purchased from Sigma-Aldrich, St. Louis, MO,
United States. The RVG-Lamp2b plasmid was a gift from Drs.
Seow Yiqi and Matthew Wood at the University of Oxford,
Oxford, United Kingdom (Alvarez-Erviti et al., 2011).
Animals
All animal procedures were performed according to the protocols
approved by the Institutional Animal Care and Use Committee
of the University of Nebraska Medical Centre and the National
Institutes of Health. C57BL/6N mice were purchased from
Charles River Laboratories (Wilmington, MA, United States) and
housed under standard vivarium conditions. Food and water
were available ad libitum (Chivero et al., 2017). C57BL/6 wild
type mice were divided into two groups; receiving either cocaine
or saline injections (20 mg/kg, i.p.) for seven consecutive days.
Three days prior to sacrifice, mice were intranasally administered
dendritic cell-derived EVs loaded with either Cy5-miR-124 or
Cy5-scrambled miRNAs or left unloaded, followed by cocaine
i.p. injections 1-h post-EV delivery. Mice were sacrificed on the
seventh day followed by removal of brain tissues for analysis for
protein/RNA analysis and immunohistochemistry.
Isolation of Mouse Primary Microglia
Mouse primary microglial cells were isolated from
C57BL/6N newborn mice pup brains as described previously
(Liao et al., 2016; Chivero et al., 2017). Briefly, brain cortices
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were dissociated and digested in Hank’s buffered salt
solution (14025076, Invitrogen, Carlsbad, CA, United States)
supplemented with 0.25% trypsin (25300-054, Invitrogen,
Carlsbad, CA, United States). Mixed glial cultures were prepared
by resuspending cells in culture medium (DMEM supplemented
with 10% heat-inactivated fetal bovine serum (FBS) with 100
U/ml penicillin, and 0.1 mg/ml streptomycin) as previously
described (Guo et al., 2015). Cells were transferred to T-75
cell culture flasks (10 × 106 cells/flask) and incubated at
37◦C and 5% CO2 and half of the cell medium was replaced
every 3–5 days. At the first medium change, macrophage
colony-stimulating factor (GF026, Millipore, St. Louis, MO,
United States) was added (0.25 ng/ml) to promote microglial
proliferation. Confluent mixed glial cultures (7–10 days)
were shaken at 37◦C, 220 × g for 2 h to promote microglia
detachment. Cell medium containing released microglia cells
was aspirated, centrifuged at 1000 × g for 5 min and collected
microglia subsequently plated on cell culture plates for all
ensuing experiments. The purity of isolated microglia was
confirmed by immunohistochemical staining for Iba1 and
was routinely found to be >95% pure (Guo et al., 2015;
Chivero et al., 2017).
DC 2.4 Mouse Dendritic Cells
The DC2.4 mouse dendritic cell line was purchased from
Millipore (# SCC142). These cells were routinely maintained
at 37◦C in 5% CO2 in RPMI supplemented with 10 % heat-
inactivated fetal calf serum, 1 X L-Glutamine (TMS-002-C,
EMD Millipore, MA, United States), 1X non-essential amino
acids (TMS-001-C; EMD Millipore, MA, United States), 1X
HEPES Buffer Solution (TMS-003-C; EMD, Millipore, MA,
United States), 0.0054X β-Mercaptoethanol (ES-007-E; EMD
Millipore, MA, United States), 100 IU/ml Penicillin and
100 µg/ml streptomycin.
Isolation and Quantification of EVs
Extracellular vesicles were prepared from the supernatant
fluids of DC2.4 dendritic cells by differential centrifugation as
previously described (Hu et al., 2018). In brief, cell culture
supernatants were harvested, centrifuged at 1000 × g for
10 min to remove dead cells followed by a further spin at
10,000 × g for 30 min and subsequent filtration through a
0.22 µm filter to remove any remaining cell debris. Next, the
EVs were pelleted by ultracentrifugation (Beckman Ti70 rotor;
Beckman Coulter, Brea, CA, United States) at 100,000 × g for
70 min. CD63 and Lamp2 were detected by western blot as
exosome markers. Purified EV nanoparticle tracking analysis
(NTA) was performed using ZetaView Nanoparticle Tracking
Analyser (Particle Metrix, Germany) as previously reported
(Dagur et al., 2020). Briefly, the instrument was calibrated using
the 100 nm polystyrene nano-standard particles followed by
loading of 1 mL of each sample (diluted in 0.20 µm filtered
PBS). Particle tracking, concentration and video acquisition was
carried out with camera sensitivity set to 85, a shutter speed
of 100 and a frame rate of 30 according to the manufacturer’s
software instructions.
Small Interfering RNA (siRNA)
Transfection
Plasmid and siRNA transfections were performed using
Lipofectamine 2000 (11668027; Life Technologies, CA,
United States) according to the manufacturer’s instructions.
In brief, cells were transfected with plasmid (500 ng) or targeted
siRNA (20 pM), mixed with 6 µl of Lipofectamine 2000 diluted
in 150 µl Opti-MEM Reduced Serum Medium (31985062; Life
Technologies, CA, United States). The resulting siRNA-lipid
complexes were added to the cells, incubated for 6 h, and the
medium changed into fresh DMEM. Next, the medium was
changed to 10% FBS-containing medium for 20 h incubation.
The transfected cells were then ready for use in experiments.
Sequences of mouse Dicer1 siRNA oligonucleotides used in
this study were: mouse Dicer1-si S1, 5′-GrUrGrUrCrArUrC
rUrUrGrCrGrArUrUrCrUrArUrUr-3′; mouse Dicer1-si AS1,
5′-UrArGrArArUrCrGrCrArArGrArUrGrArCrArCr UrUr-3′;
mouse Dicer1-siS1, 5′-CrCrArArCrUrArCrCrUrCrArUrArUr
CrCrCrArUrUr-3′; and mouse Dicer1-si AS2, 5′-UrGrGr
GrArUrArU rGrArGrGrUrArGrUrUrGrGrUrUr-3′.
miRNA Transfection of EVs
Extracellular vesicles were transfected with miRNA using
ExoFect Exosome Transfection Reagent (SBI; System
Biosciences, Palo Alto, CA, United States) according
to the manufacturer’s instructions. Mouse miR-124
oligonucleotides used in this study were synthesized at IDT
(Iowa City, IA, United States). Sequences of mouse miR-124
oligonucleotides used in this study were: Cy5-miR-124 –
5′cy5-uaaggcacgcggugaaugcc-cy5-3′; Cy5-scrambled RNA -
5′cy5-gaucgaaccuagacuaguggu-cy5-3′, that does not recognize
any sequences in mouse transcriptomes. EVs were dissolved in
sterile PBS for exposure to microglia or intranasal administration
in mice.
Intranasal Delivery of EVs
C57BL/6N 8 week-old male mice were anesthetized with
low dose isoflurane and placed in a supine position in
an anesthesia chamber. Delivery of EV-Cy5-miR-124,
EV-Cy5-scrambled-miRNA, or control EVs (20 µg/100
µL) via droplets was administered intranasally using a
pipette every 2–3 min into alternate sides of the nasal
cavity, for a total of 10 min as previously described (Hu
et al., 2018). Biodistribution of EVs in the brain, liver
and spleen tissues was determined using a Xenogen IVIS
200 imager.
Western Blotting
Mouse brain tissue homogenates or microglial cells exposed
to EVs were lysed with RIPA buffer supplemented with a
protease inhibitor cocktail (78430; Thermo Fisher Scientific,
CA, United States) followed by ultrasonication for 15 s,
at 80% amplitude. Western blotting was performed
as previously described (Chivero et al., 2017, 2019).
Densitometric analyses were performed using NIH ImageJ
software (ImageJ v1.44, NIH) as previously described
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(Chivero et al., 2019). Protein amounts for bands of interest
were normalized to β -actin.
Immunohistochemistry
Immunofluorescence staining for Iba1 was performed in the
whole brain sections of mice intranasally administered dendritic
cell-derived EVs loaded with either Cy5-miR-124, Cy5-scrambled
miRNA or were left unloaded, followed by 20 mg/kg cocaine
injections (n = 4). Briefly, four sections from each brain were
processed for the immunostaining. The brain sections were
washed three times with PBS, permeabilized with 0.3% Triton
X-100 in PBS for 30 min as previously described (Liao et al.,
2016). The tissues were then blocked with 10% goat serum in PBS
for 2 h followed by overnight co-incubation with Iba1 primary
antibody at 4◦C. Next day, the slides were washed with PBS three
times, followed by incubation with corresponding secondary
Alexa Fluor 488 goat anti-rabbit (A-11032; Invitrogen, Carlsbad,
CA, United States) for 2 h. Finally, the slides were washed with
PBS for three times and mounting with ProLong Gold Antifade
Reagent with DAPI. Fluorescent images (2–3 images per section)
were taken on a Zeiss Observer using a Z1 inverted microscope
(Carl Zeiss, Thornwood, NY, United States). The fluorescence
intensity, surface area and cell number of Iba-1 + cells were
analyzed using the ImageJ software.
Statistical Analysis
Graphs and statistical analyses were performed using GraphPad
software V6.0 (GraphPad Prism Software). Student’s t-test was
used to compare results between tests and controls. One-way
ANOVA was used for multiple comparisons. P-values less than
0.05 were considered statistically significant.
RESULTS
Characterization of EVs Derived From
Dendritic Cells
Dendritic cells are sentinel antigen-presenting cells of the
immune system that produce high levels of EVs. Both dendritic
cells as well as EVs derived from dendritic cells are known to
possess MHC-I and MHC-II molecules as well as costimulatory
molecules, which, in turn, facilitates interaction with immune
cells (Pitt et al., 2016). They also possess a variety of surface
adhesion membrane proteins, which allow for effective targeting
and docking to recipient cells (Pitt et al., 2016). Since dendritic
cell-derived EVs can communicate with several cell types, we
chose to make EVs from dendritic cells as donor EVs. Herein
we first sought to engineer dendric cell-derived EVs by co-
transfection of mouse dendritic cells with Dicer siRNA and
RVG-Lamp2b plasmid to deplete endogenous miRNAs and for
targeting the CNS, respectively. As shown in Figures 1A,B,
there was efficient knockdown of dicer and over-expression of
Lamp2b in these cells following dicer siRNA and RVG-Lamp2b
co-transfection.
We next isolated and characterized EVs from these engineered
dendritic cells using a differential ultracentrifugation procedure
(Figure 1C). Purified EVs were counted and characterized
by their size and by western blot for signature EV markers.
As shown in Figure 1D, dicer knockdown by siRNA did
not significantly affect the production of EVs as shown
by EV counts using Zetaview. EV size ranged from 40 to
150 nm in diameter (Figure 1E). Additionally, levels of
selected miRs in these EVs were assessed by qPCR. As
shown in Supplementary Figure 1C, levels of selected miR-
138 and miR-223 were markedly reduced in EVs isolated
from Dicer knockdown cells. Immunoblotting of the EV
lysates revealed the presence of exosomal markers CD63 and
Lamp2b (Figure 1F).
Dendritic Cell-Derived EVs Loaded With
Cy5-miR-124 Are Taken Up by Microglia
and Inhibit Cocaine-Mediated Microglial
Activation
We next transfected dendric cell-derived EVs with Cy5-miR-
124 mimic oligos and asked whether these EVs could be
taken up by microglia, the primary immune cells within the
CNS, and inhibit miR-124 target genes that are upregulated
upon cocaine exposure. As shown in Figure 2A, mouse
primary microglia exposed to EVs transfected with Cy5-miR-
124 (1 h) demonstrated a cytoplasmic and perinuclear Cy5
fluorescence suggesting thereby that EVs were taken up by
microglial cells (Figure 2A). Since cocaine has been shown
to downregulate the expression of miR-124 and consequently
upregulate the expression of TLR4 and STAT3, known targets
of miR-124 (Periyasamy et al., 2017), we next sought to
assess the expression of TLR4 and STAT3 in mouse primary
microglial cells exposed to EVs loaded with miR-124 mimic
or scrambled miR-124, followed by exposure to cocaine
(10 µM). As shown in Figure 2B, exposure of microglia
to cocaine in cells exposed to scrambled miRNA-loaded
EVs resulted in increased expression of TLR4 compared
with control cells. In cells exposed to EVs loaded with
miR-124 oligos (EV-miR-124), however, cocaine failed to
upregulate the expression of TLR4. As shown in Figure 2C,
EVs loaded with miR-124 similarly inhibited the expression
of STAT3 in microglia exposed to cocaine compared with
cells exposed to cocaine in the presence of scrambled
miRNA control.
Having demonstrated that dendritic cell-derived EVs can
deliver functional miR-124 to microglia, which, in turn, reduces
the expression of key proinflammatory mediators, TLR4 and
STAT3, we next sought to investigate the effects of miR-124
on microglial activation. For this mouse primary microglia
were exposed to EVs loaded with either miR-124 mimic or
scrambled miR-124, followed by exposure of microglia to
cocaine and assessed for the expression of Iba1 and ERK1/2
by western blotting. As shown in Figures 2D,E, exposure
of microglia to cocaine resulted in significant upregulation
of ERK1/2 and Iba1 expression compared with control cells.
In the presence of miR-124-EVs, however, cocaine failed to
upregulate the expression of both these markers. Collectively,
these results imply that miR-124 delivered via EVs blocked
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FIGURE 1 | Characterization of dendritic cell-derived EVs: Expression levels of dicer (A) and Lamp2b (B) in mouse DC2.4 dendritic cell line co-transfected with dicer
siRNA and RVG-Lamp2b plasmid. (C) Extracellular vesicles (EVs) were isolated from the culture supernatants of engineered DC2.4 mouse dendritic cells by a series
of centrifugation. (D) Zeta view count of EVs. (E) Size distribution of EVs. (F) Western blot images for the expression of CD63 and Lamp2 in purified EVs. All
experiments were done at least three independent times, and representative figures are shown. Actin served as a loading control for western blots in B. ∗p < 0.05
vs. control.
cocaine-mediated microglial activation via inhibition of TLR4,
STAT3, and ERK1/2 expression.
Intranasal Delivery of Dendritic
Cell-Derived EVs Loaded With
Cy5-miR-124 Inhibits Cocaine-Mediated
Activation of Microglia in vivo
Having demonstrated that dendritic cell-derived EVs can deliver
functional miR-124 to microglia and modulate the expression
of both proinflammatory and activation mediators in vitro,
we next sought to validate these observations in vivo. Wild-
type C57BL/6N mice were administered with either cocaine
(20 mg/kg; i.p.) or saline for 7 consecutive days. On the fifth
day up to the seventh-day mice were intranasally administered
dendritic cell-derived EVs loaded with either Cy5-miR-124
or Cy5-scrambled miRNAs or EVs that were left unloaded,
followed by cocaine injections 1 h later (see schematic in
Figure 3A). Mice were sacrificed within 4 h after the last
injection, perfused with ice-cold PBS, followed by tissue
harvesting. The efficacy of EV delivery and biodistribution
were monitored using the in vivo imaging system (IVIS)
and the functional analysis for inflammation and activation
pathways in the brain were also performed. As shown in
Supplementary Figure 3A, IVIS imaging of organs showed
that the Cy5 signal was detectable in the brain and liver
at 4 h post-intranasal delivery. We next analyzed for the
expression levels of miR-124 and as shown in Figure 3B, levels
of miR-124 were reduced in the cortex of mice administered
cocaine compared with saline controls. Next, we sought to
examine the attenuation of cocaine-mediated upregulation of
Iba1 expression in the cortex, by assessing expression of
Iba1 by western blotting in mice pretreated with EV-cy5-
miR-124 and administered cocaine. As shown in Figure 3C,
there was downregulation of Iba1 in the cortex of mice
pretreated with EV-Cy5-miR-124 in the presence of cocaine
compared with levels of Iba1 in control mice administered
cocaine and control EVs. Next, we sought to examine the
uptake of labeled EVs by microglia in sections of both the
striatum and the cortex by assessing Cy5+ and Iba1+ double
immunopositive cells. As shown in Figures 3D,F, Cy5 signal
was detected in microglia present in both the cortical and
striatal regions (indicated by arrows), thus suggesting the
uptake of Cy5-miR-124 EVs by these cells. Interestingly, as
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FIGURE 2 | Dendritic cell-derived EVs loaded with Cy5-miR-124 are taken up by microglia and inhibit cocaine-mediated microglial activation. (A) Representative
images of mouse primary microglia exposed to EVs transfected with Cy5-miR-124 or Cy5-scrambled miRNA (1 h) showing the presence of intracellular Cy5. (B–E)
Expression of TLR4, STAT3, ERK and Iba-1 in mouse primary microglial cells pretreated with EVs loaded with miR-124 mimic or scrambled miRNA followed by
exposure to cocaine (10 µM). All experiments were done at least three independent times, and representative figures are shown. Actin served as a loading control for
western blots. Quantification of western blots is shown under each blot. Data are shown as mean ± SEM. ∗p < 0.05 vs. control, #p < 0.05 vs. cocaine group.
expected and as shown in Figure 3D, cocaine administration
in the presence of control EVs (intranasal) resulted in
upregulated expression of Iba1 in microglia in the cortex
compared with that of mice administered with saline and
control EVs (intranasal). In mice pretreated with EVs-Cy5-
miR-124 intranasally, however, cocaine failed to upregulate
the expression of Iba1 (Figure 3D). Quantification of Iba
1 fluorescent intensity normalized to the total number of
Iba1+ cells in mice brains is shown in Figure 3E. We also
analyzed striatal tissue sections and found similar findings
as that shown for cortex, specifically that Cy5-miR-124 EVs
abrogated cocaine-induced upregulation of Iba1 as evidenced
in Figure 3F and quantified in Figure 3G. In addition, we
also normalized the surface area of Iba1+ cells to the total
number of Iba1+ cells and obtained similar results as shown
in Supplementary Figures 3C,D.
Having established the functional effects of Cy5-miR-124 on
the expression of Iba1 in vivo, we further investigated whether
the targets of miR-124 such as TLR4, STAT3, NF-kB p65 and
MYD88 could be modulated by exogenous intranasally delivery
of EV-Cy5-miR-124 in cocaine administered mice. As shown in
Figure 4A and as expected, administration of cocaine resulted in
upregulated expression of TLR4 compared with control animals.
However, in mice pretreated with EV-Cy5-miR-124, cocaine
failed to upregulate the expression of TLR4. Previous studies
have shown that miR-124 negatively regulates TLR4-mediated
signaling by modulating the expression of MYD88 that is a TLR4
downstream signal (Periyasamy et al., 2017). To confirm whether
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FIGURE 3 | Intranasal delivery of dendritic cell-derived EVs loaded with Cy5-miR-124 inhibits cocaine-mediated upregulation of Iba-1 in vivo. Wild-type C57BL/6N
mice were administered cocaine (20 mg/kg; i.p.) or saline for seven consecutive days. On the fifth, sixth and seventh days, mice were intranasally administered
dendritic cell-derived EVs loaded with Cy5-miR-124 or Cy5-scrambled miRNA or were left unloaded, followed by cocaine injections (i.p.). (A) Scheme for intranasal
administration of EVs and cocaine injections. (B) Expression levels of miR-124 in the cortex. (C) Western blot for Iba1 in the cortex. Actin served as a loading control.
(D) Representative immunofluorescence staining images for Iba1 in mice cortical sections from the four groups of mice i.e., saline + control EVs; cocaine + control
EVs; cocaine + EV-Cy5-scrambled miRNA (sham); cocaine + EV-Cy5-miR-124. The blown-out sections show Iba1+cy5+ microglial cells indicated by arrows.
(E) Quantification of Iba1 fluorescence intensity normalized to the number of Iba1+ cells in the cortex. (F) Representative immunofluorescence staining images for
Iba-1 in the striatum from the four groups of mice. (G) Quantification of Iba1 fluorescence intensity intensity normalized to the number of Iba1+ cells in the striatum.
(n = 4/group, ∗p < 0.05 vs. saline+ EV control, #p < 0.05 vs. cocaine+ EV control group, one way ANOVA, Turkey’s multiple comparisons test).
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miR-124 delivered by EVs could also modulate the expression of
MYD88, we analyzed for the expression of MYD88 in cortical
tissues and found that miR-124 loaded EVs attenuated cocaine-
induced upregulation of MYD88 (Figure 4B). Since miR-124 is
also known to regulate NF-kB p65 and STAT 3, we also analyzed
the expression of these mediators in these mice. The results
demonstrated that NF-kB p65 and STAT3 were downregulated
in mice administrated with cocaine and EV-Cy5-miR-124 pre-
treatment compared with mice administered with cocaine or
saline and control EVs, respectively (Figures 4C,D).
DISCUSSION
Finding an effective and less invasive method for the delivery of
microRNA-based drugs into the brain remains a major challenge
in the field (Zhuang et al., 2011). In the current study, we loaded
EVs produced by dendritic cells with miR-124 for delivery into
mouse primary microglia in vitro and also for delivery into
the brain via the intranasal route in a mouse model of cocaine
administration in vivo. Dendritic-cell derived EVs were taken up
by mouse primary microglia in vitro and as well as into the brains
FIGURE 4 | Intranasal delivery of dendritic cell-derived EVs loaded with Cy5-miR-124 inhibits cocaine-mediated upregulation of TLR4, MYD88, STAT3 and NF-kB
p65 in vivo. Wild-type C57BL/6N, mice were administered either cocaine (20 mg/kg; i.p.) or saline for seven consecutive days. On the fifth, sixth, and seventh days,
mice were intranasally administered dendritic cell-derived EVs loaded with Cy5-miR-124 or Cy5-scrambled miRNAs or were left unloaded, followed by cocaine
injection. (A–D) Western blot images depicting the effect of EV-miR-124 on the expression of TLR4, MYD88, STAT3 and NF-kB p65. Actin served as a loading
control. Quantification of western blots is shown under each blot. Data are shown as mean ± SEM (n = 4/group, ∗p < 0.05 vs. saline+ EV control, #p < 0.05 vs.
cocaine+ EV control group).
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of mice following intranasal administration. Increased levels of
miR-124 were found to attenuate cocaine-mediated upregulation
of TLR4, MYD88, NF-kB p65 and STAT3 – mediators critical for
cocaine-mediated neuroinflammation. Additionally, there was
also reduced expression of the microglial marker Iba1 in the
presence of EV-miR-124. Our results thus suggest that dendritic
cell-derived EVs can deliver miR-124 to the CNS, thereby
alleviating cocaine-mediated microglial activation.
Dendritic cells are sentinel antigen-presenting cells of
the immune system that are known to communicate with
neighboring cells through soluble mediators, cell-to-cell-contact
and vesicle exchange (Montecalvo et al., 2012) and via release
of a vast number of EVs. In addition, dendritic cells and the
EVs they produce possess MHC-I and MHC-II molecules as
well as costimulatory molecules, which interact with immune
cells (Pitt et al., 2016). These cells and their EVs also possess a
variety of surface adhesion membrane proteins such as integrins,
immunoglobulin family member ICAM-1, and milk fat globule
EGF factor 8 (MFG-E8) which facilitates effective targeting and
docking to recipient cells (Pitt et al., 2016). Since dendritic cell-
derived EVs can communicate with several cell types, herein,
we isolated EVs from dendritic cells and loaded them with Cy5-
miR-124 for uptake by microglia both in vitro and in vivo. Here
we used EVs derived from the DC2.4 dendritic cell line that
has been well characterized and exhibits features of dendritic
cells including the expression of dendritic cell-specific markers,
cell morphology and has the ability to phagocytose and present
exogenous antigens on both MHC class I and class II molecules
(Shen et al., 1997). Our findings suggest that microglia can take
up these EVs both in vitro and in vivo. This is particularly relevant
since microglia play critical roles in modulating cocaine-induced
inflammation (Guo et al., 2015, 2016; Periyasamy et al., 2017).
Ability to deliver functional anti-inflammatory miRNAs to these
cells could be useful for neuroinflammatory diseases. It was also
seen that in addition to microglia other cell types in the brain
could also take up EVs. Further studies are warranted to examine
the potential side effects of miR-124 in these cells.
Presence and enrichment of miRNAs in EVs have been well-
documented (Penfornis et al., 2016; Bayraktar et al., 2017).
Endogenous miRNAs in EVs have been shown to affect the
cellular functions of recipient cells via various mechanisms
(Bayraktar et al., 2017). Furthermore, knockdown of dicer in
donor cells has been shown to deplete the presence of miRNAs
in the EVs isolated from these dicer knock out cells (Squadrito
et al., 2014). In the current study, we attempted to limit the
off-target effects of miRNAs in EVs by knocking down dicer
using the siRNA approach. We do acknowledge that besides
miRs, EVs are also endowed with cargo containing proteins and
lipids that could lead to off-target effects that need to be yet
characterized. As a means to increase the specific delivery of EVs
into the CNS, we followed the approach reported by Alvarez-
Erviti et al. (2011) wherein the authors were able to successfully
express Lamp2b, an EV membrane protein, fused to an rabies
virus glycoprotein (RVG) peptide in dendritic cells, followed
by loading the EVs isolated from these cells with exogenous
siRNA of GAPDH. RVG peptide is known to target the alpha-7-
subunit of the nicotinic acetylcholine receptor (Kim et al., 2010),
and facilitates the transcytosis of the EVs across the blood-
brain barrier, with specific targeting of neural cells in the brain
(Loddo et al., 1966; Alvarez-Erviti et al., 2011). It was reported
that intravenously injected RVG EVs delivered GAPDH siRNA
specifically to the neurons, microglia and oligodendrocytes in
the brain, resulting in tissue-specific gene knockdown (Alvarez-
Erviti et al., 2011). In agreement with these findings, our data also
demonstrated delivery to the brain of Cy5-miR-124 using these
Lamp2-RVG tagged EVs.
It has been well-recognized thatmiR-124 is highly expressed in
microglia and is critical for maintaining microglia in a quiescent
state (Ponomarev et al., 2011; Veremeyko et al., 2013; Svahn
et al., 2016). Cocaine has been shown to downregulate expression
of miR-124 in microglia with concomitant upregulation of its
targets – KLF4 and TLR4 (Guo et al., 2016; Periyasamy et al.,
2017). Interestingly, overexpression of lentivirus miR-124 by
stereotactic injection was shown to inhibit microglial activation
in cocaine-administered mice (Periyasamy et al., 2017). The
current study was aimed at developing a non-invasive method
for miR-124 delivery into the brain using brain targeted EVs.
Our in vitro findings suggested that a physiologically relevant
dose of cocaine (10 µM) resulted in significant upregulation
of proinflammatory mediators (TLR4, STAT3) and that this
effect was attenuated by EV-miR-124. It has been shown that
the plasma levels of cocaine in humans who inhale cocaine
intranasally ranges between 0.4 and 1.6 µM (Van Dyke et al.,
1976) while the plasma cocaine levels in tolerant abusers was
found to be 13 µM (Stephens et al., 2004). Further, the levels
of cocaine in the postmortem brains of chronic cocaine users
with acute intoxications have been found to be greater than 100
µM (Kalasinsky et al., 2000). Cocaine concentrations used in this
study are in keeping with the physiological levels observed in
humans abusing cocaine. Our in vivo findings demonstrated that
intranasal delivery of EVs loaded with miR-124 could reach the
brain, leading, in turn, to downregulated expression of TLR4 and
other miR-124 target genes, ultimately resulting in amelioration
of microglial activation in cocaine-administered mice.
In summary, our findings demonstrate that intranasal delivery
of CNS target peptide-engineered EVs (from dicer-deficient
dendritic cells) loaded with miR-124 have the potential to
abrogate cocaine induced-microglial activation in vivo. In
summary, manipulating EV miRNAs can be envisioned as an
efficient means for RNA drug delivery to target organs, such as
the brain, for the treatment of neuroinflammatory diseases such
as cocaine addiction.
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